Monograph: Bismuth Salts

Bismuth Salts

Die Inhalte stehen nur registrierten Benutzern zur Verfügung.

Sie sind zum ersten mal hier und möchten die Datenbank 10-Tage kostenlos testen, dann registrieren Sie sich einmalig. Nach der Registrierung melden Sie sich mit Ihrem Benutzernamen und Passwort an.

Sie sind bereits bei DrugBase registriert und möchten diese Datenbank 10-Tage kostenlos und unverbindlich testen? Dann melden Sie sich mit Ihren Zugangsdaten an und wählen Sie anschließend die Datenbank, die Sie testen möchten.

Full Title

Bismuth Salts

Generic Name

Bismuth Subcitrate Potassium; Bismuth Subgallate; Bismuth Subsalicylate

Synonym

...

Classification

CAS Number

...

Introduction

Introduction

...

...

Description

...

...

Uses

Uses

...

Diarrhea

...

Helicobacter pylori Infection and Duodenal Ulcer Disease

...

Flatulence or Stool Odor

...

Dyspepsia (Upset Stomach)

...

...

Dosage and Administration

Dosage and Administration

...

Administration

...

Oral Administration

...

Capsules

...

Suspension

...

Chewable Tablets

...

Conventional Tablets

...

Dosage

...

Acute Nonspecific Diarrhea and Travelers’ Diarrhea

...

Bismuth Subsalicylate

...

Prevention of Travelers’ Diarrhea

...

Bismuth Subsalicylate

...

Helicobacter pylori Infection and Duodenal Ulcer Disease

...

Bismuth Subsalicylate, Metronidazole, and Tetracycline Hydrochloride Regimen

...

Bismuth Subsalicylate (with Metronidazole and Tetracycline Hydrochloride) in Helidac® Therapy Kit

...

Fixed Combination Containing Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Hydrochloride (Pylera®)

...

Flatulence or Stool Odor

...

Bismuth Subgallate

...

Dyspepsia (Upset Stomach)

...

Bismuth Subsalicylate

...

Special Populations

...

...

Cautions

Cautions

...

Contraindications

...

Warnings/Precautions

...

Warnings

...

GI Disorders

...

Reye’s Syndrome

...

Neurotoxicity

...

Discoloration of Tongue and/or Stool

...

Lead Content

...

Sensitivity Reactions

...

Hypersensitivity

...

General Precautions

...

Selection and Use of Anti-infectives in H. pylori Regimens

...

Phenylketonuria

...

Medication Errors

...

Use of Fixed Combinations or Multiple-Drug Kits

...

Laboratory Test Interferences

...

Specific Populations

...

Pregnancy

...

Lactation

...

Pediatric Use

...

Geriatric Use

...

Hepatic Impairment

...

Renal Impairment

...

Common Adverse Effects

...

...

Drug Interactions

Drug Interactions

...

Anticoagulants

...

Antidiabetic Agents

...

Aspirin

...

Ciprofloxacin

...

Doxycycline

...

Methotrexate

...

Omeprazole

...

Probenecid

...

Salicylates

...

Sulfinpyrazone

...

Tetracycline

...

...

Pharmacokinetics

Pharmacokinetics

...

Absorption

...

Bioavailability

...

Food

...

Distribution

...

Extent

...

Plasma Protein Binding

...

Elimination

...

Metabolism

...

Elimination Route

...

Half-life

...

Special Populations

...

...

Advice to Patients

Advice to Patients

...

...

Preparations

Preparations

...

Bismuth Subcitrate Potassium Combinations

...

Bismuth Subgallate

...

Bismuth Subsalicylate

...

Bismuth Subsalicylate Combinations

...

...

Common general statement Elements

Additional Information

...

...

References

References

...

...

Copyright

AHFS® Drug Information. © Copyright, 1959-2020, Selected Revisions February 1, 2011. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

† Use is not currently included in the labeling approved by the US Food and Drug Administration.

Quelle

AHFS Drug Information